Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Central Imaging Review Analysis with mint Lesion

Central Imaging Review Analysis with mint Lesion - read-ready in minutes, not weeks

Watch in the video above a demonstration of our central imaging review software featuring a pre-configured, master trial workflow database designed to support your study requirements with read-ready functionality quickly available.

  • Multiple read paradigms: Support for single reads, double reads with adjudication, and eligibility workflows
  • Multi-criteria reads: Apply multiple evaluation frameworks to the same image
  • Flexible templates: Use standard response criteria read templates or custom eCRFs you design
  • Built-in analytics: Volumetrics, SUVs, tumor growth rates, and radiomics capabilities
  • Automated notifications: Alerts configured to align with your review flow
  • Export functionality: One-click exports for images, data (CDISC, radiomics, observations), and structured results

 

Related Resources

Related Resources

Update RSNA - Oncologic Imaging & Interventions

01/12 to 01/13/2024 MATERNUSHAUS, COLOGNE, GERMANY

University Hospital Cologne, Institute for Diagnostic and Interventional Radiology - In-person event

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…